NCT06732011Not yet recruiting
Evaluation of Brain Dysfunction in Patients with Duchene Muscular Dystrophy
Source: ClinicalTrials.gov · Last updated 13 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To study the cognitive function \& psychiatric aspects of patients with DMD by specific psychometry tests \& its relation to quality of life of the patients To evaluate brain structural changes using MRI and correlate them to the cognitive \& psychiatric manifestations of the patients To correlate the cognitive function with the neurophysiological tests and imaging done to the patient
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 42 (estimated)
- First submitted
- 10 Dec 2024
- Start date
- 30 Dec 2024
- Primary completion date
- 30 Jan 2026
- Lead sponsor
- Assiut University
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT06732011
What you commit to
- Study type: Observational
- Planned participants: 42
- From 30 Dec 2024 to the primary completion date, 30 Jan 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Medical or neurological condition affecting cognition (as endocrinal as Diabetes Mellitus \& hypothyroidism, autoimmune disease, history of brain trauma, birth asphyxia, neonatal jaundice, …..) Surgical condition that could potentially impact cognitive function Patients of other types of muscular dystrophy Those who refuse to participate in the study Those with sensory disability (as hearing loss, blindness, severe speech delay) Those with non-invasive or invasive ventilation support with inability to speak and answer oral questions
Who the study is looking for
- \- Male patients Age children \& adolescent (5-18yrs) Patients diagnosed \& genetically confirmed DMD, with cross matching of healthy subjects of the same age and number
Age in the registry: 5 years to 18 years · Sex: Male · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.